Diagnostic performance of 18F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease

Lung

Volumn 186, Issue 5, 2008, Pages 327-336

  An, Young Sil ^a   Sun, Joo Sung ^a   Park, Kyung Joo ^a   Hwang, Sung Chul ^a   Park, Kwang Joo ^a   Sheen, Seung Soo ^a   Lee, Sungsoo ^a   Lee, Kyi Beom ^a   Yoon, Joon Kee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

18F FDG; Inflammatory lung disease; Lymph node staging; Non small cell lung cancer; PET CT; ROC curve analysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOMEPROL;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; ATELECTASIS; BRONCHUS OBSTRUCTION; CANCER STAGING; CANCER SURGERY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; LOBECTOMY; LUNG ABSCESS; LUNG ADENOCARCINOMA; LUNG INFECTION; LUNG MYCOSIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PLEURA EMPYEMA; PNEUMOCONIOSIS; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUBERCULOSIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; LUNG DISEASES; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52449100615     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-008-9109-3     Document Type: Article

References (35)

1. S Stroobants J Verschakelen J Vansteenkiste 2003 Value of FDG-PET in the management of non-small cell lung cancer Eur J Radiol 45 49 59 10.1016/S0720-048X(02)00282-6
2. E Salminen M MacManus 2002 FDG-PET imaging in the management of non-small-cell lung cancer Ann Oncol 13 357 360 10.1093/annonc/mdf106
3. Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF Jr, Lafitte JJ, Sculier JP, European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project (2008) Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3:6-12
4. 18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives Radiother Oncol 81 209 225 10.1016/j.radonc.2006.09.011
5. RJ Cerfolio B Ojha AS Bryant CS Bass AA Bartalucci JM Mountz 2003 The role of FDG-PET scan in staging patients with nonsmall cell carcinoma Ann Thorac Surg 76 861 866 10.1016/S0003-4975(03)00888-9
6. D Lardinois W Weder TF Hany EM Kamel S Korom B Seifert GK von Schulthess HC Steinert 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2500 2507 10.1056/NEJMoa022136
7. GW Goerres GK von Schulthess HC Steinert 2004 Why most PET of lung and head-and-neck cancer will be PET/CT J Nucl Med 45 66S 71S
8. G Antoch J Stattaus AT Nemat S Marnitz T Beyer H Kuehl A Bockisch JF Debatin LS Freudenberg 2003 Non-small cell lung cancer: dual-modality PET/CT in preoperative staging Radiology 229 526 533 10.1148/radiol.2292021598
9. BA Dwamena SS Sonnad JO Angobaldo RL Wahl 1999 Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT Radiology 213 530 536
10. Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM, Onko-PET der Deutschen Gesellschaft fur Nuklearmedizin (2001) Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000. Pneumologie 55:367-377 [in German]
11. 18F]FDG-PET Thorac Cardiovasc Surg 52 96 101 10.1055/s-2004-817844
12. W Yang Z Fu J Yu S Yuan B Zhang D Li L Xing D Zhao D Mu X Sun Y Fang Y Huange W Li 2008 Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer Lung Cancer 61 35 43 10.1016/j.lungcan.2007.11. 007
13. SS Shim KS Lee BT Kim MJ Chung EJ Lee J Han JY Choi OJ Kwon YM Shim S Kim 2005 Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging Radiology 236 1011 1019 10.1148/radiol.2363041310
14. PD Shreve Y Anzai RL Wahl 1999 Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 61 77
15. K Takamochi J Yoshida K Murakami S Niho G Ishii M Nishimura Y Nishiwaki K Suzuki K Nagai 2005 Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients Lung Cancer 47 235 242 10.1016/j.lungcan.2004.08.004
16. J Konishi K Yamazaki E Tsukamoto N Tamaki Y Onodera T Otake T Morikawa I Kinoshita H Dosaka-Akita M Nishimura 2003 Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings Respiration 70 500 506 10.1159/000074207
17. C Turkmen K Sonmezoglu A Toker D Yilmazbayhan S Dilege M Halac M Erelel T Ece A Mudun 2007 The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high Clin Nucl Med 32 607 612 10.1097/RLU.0b013e3180a1ac87
18. YK Kim KS Lee BT Kim JY Choi H Kim OJ Kwon YM Shim CA Yi HY Kim MJ Chung 2007 Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients Cancer 109 1068 1077 10.1002/cncr.22518
19. TP Graeter D Hellwig K Hoffmann D Ukena CM Kirsch HJ Schäfers 2003 Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy Ann Thorac Surg 75 231 236 10.1016/S0003-4975(02)04350-3
20. A Rodríguez Fernández M Gómez Río JM Llamas Elvira A Sánchez-Palencia Ramos M Bellón Guardia C Ramos Font P Torné Poyatos V Pedraza Muriel 2007 Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer Clin Transl Oncol 9 32 39 10.1007/s12094-007-0007-6
21. 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer Jpn J Thorac Cardiovasc Surg 53 196 198 10.1007/s11748-005-0104-9
22. M Schmücking RP Baum R Bonnet K Junker KM Müller 2005 Correlation of histologic results with PET findings for tumor regression and survival in locally advanced non-small cell lung cancer after neoadjuvant treatment Pathologe 26 178 189 10.1007/s00292-005-0758-1 [in German]
23. S Balogova D Grahek K Kerrou F Montravers N Younsi N Aide T Jacob JN Talbot 2003 [18F]-FDG imaging in apparently isolated pleural lesions Rev Pneumol Clin 59 275 288 [in French]
24. SY Low P Eng GH Keng DC Ng 2006 Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis Respirology 11 84 89 10.1111/j.1440-1843.2006.00789.x
25. KG Tournoy S Maddens R Gosselin G Van Maele JP van Meerbeeck A Kelles 2007 Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study Thorax 62 654 655 10.1136/thx.2006.072959
26. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? J Nucl Med 48 1761 1766 10.2967/jnumed.107.044362
27. JF Vansteenkiste SG Stroobants PR De Leyn PJ Dupont J Bogaert A Maes GJ Deneffe KL Nackaerts JA Verschakelen TE Lerut LA Mortelmans MG Demedts 1998 Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients J Clin Oncol 16 2142 2149
28. RF Yen KC Chen JM Lee YC Chang J Wang MF Cheng YW Wu YC Lee 2008 (18)F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: Is dual time point imaging worth the effort? Eur J Nucl Med Mol Imaging 35 1305 1315 10.1007/s00259-008-0733-1
29. M Hara N Shiraki M Itoh Y Shibamoto A Iida M Nishio T Tamaki 2004 A problem in diagnosing N3 disease using FDG-PET in patients with lung cancer-high false positive rate with visual assessment Ann Nucl Med 18 483 488
30. M Tatsumi K Yutani Y Watanabe S Miyoshi N Tomiyama T Johkoh H Kusuoka H Nakamura T Nishimura 1999 Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET J Nucl Med 40 566 573
31. M Tatsumi K Yutani T Nishimura 2000 Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F]FDG-PET J Comput Assist Tomogr 24 574 580 10.1097/00004728-200007000-00011
32. A Mavi M Urhan JQ Yu H Zhuang M Houseni TF Cermik D Thiruvenkatasamy B Czerniecki M Schnall A Alavi 2006 Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes J Nucl Med 47 1440 1446
33. R Kumar VA Loving A Chauhan H Zhuang S Mitchell A Alavi 2005 Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET J Nucl Med 46 1819 1824
34. R Núñez A Kalapparambath J Varela 2007 Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET Rev Esp Med Nucl 26 196 207 10.1157/13107971
35. RJ Cerfolio B Ojha AS Bryant V Raghuveer JM Mountz AA Bartolucci 2004 The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer Ann Thorac Surg 78 1017 1023 10.1016/j.athoracsur.2004.02.067